If you are a shareholder in Ampio Pharmaceuticals Inc’s (AMEX:AMPE), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolio is ...

Investors might want to bet on Ampio Pharmaceuticals (AMPE), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops ...

The Ampe A10 is one of the first Android tablets to feature a Freescale i.MX6 quad-core processor, so when the folks at PandaWill asked me if I’d like to review the tablet I jumped at the opportunity.

Ampio Pharmaceuticals, Inc. AMPE was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...